Batool Al Balooshi - Dubai nuclear Medicine and Molecular imaging Center, Dubai Hospital, Dubai Health Authority, Dubai-UAE
Shabna Miyanath - Dubai nuclear Medicine and Molecular imaging Center, Dubai Hospital, Dubai Health Authority, Dubai-UAE
Amr Elhennawy - Dubai nuclear Medicine and Molecular imaging Center, Dubai Hospital, Dubai Health Authority, Dubai-UAE
yaser Saeedi - Department of Urology, Dubai Hospital, Dubai Health Authority, Dubai-UAE

F-18 FDG is the most widely used tracer in molecular imaging and it is applied for many purposes mainly in malignant diseases. Incidental finding are common in FDG-PET/CT imaging and includes benign and malignant lesions. Among the rare tumors , adrenal oncocytomas are uncommon findings and incidental findings of thyroid malignancies are not rare. Oncocytoma is a rare adrenocortical tumor and majority of bulky adrenal tumors are benign with uncertain incident of malignancy. In this study, we are reporting a 37-year-old man with two incidental malignancies detected by FDG-PET-CT. He has no symptoms has no blood and hormonal abnormalities. The scan demonstrated intense heterogeneous FDG uptake within the bulky oval shaped lesion in the left adrenal gland. Accordingly, open adrenalectomy was performed and diagnosis of adrenocortical carcinoma oncocytic type was established. Furthermore, a focal FDG uptake was identified in the right thyroid lobe and histopathology findings were consistent with well-differentiated papillary thyroid cancer. FDG plays a great role in identifying primary rare lesions and also detection of incidental findings at unexpected sites.

F-18 FDG, adrenal mass, adrenocortical carcinoma, thyroid carcinoma, adrenal oncocytoma